Canada Markets closed

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1400+0.0050 (+3.70%)
At close: 09:30AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
2,744
-
156.733
1,608
1,342
1,694
Cost of Revenue
1,433
-
44.704
1,039
814.715
1,084
Gross Profit
1,311
-
112.029
568.441
526.859
609.912
Operating Expenses
Research Development
837.889
-
1,036
1,377
1,326
1,541
Selling General and Administrative
3,777
-
2,534
4,075
3,425
2,659
Total Operating Expenses
4,614
-
3,570
5,452
4,751
4,200
Operating Income or Loss
-3,303
-
-3,458
-4,884
-4,224
-3,590
Interest Expense
1,236
-
816.664
416.057
121.556
141.675
Total Other Income/Expenses Net
-27.018
-
237.168
327.773
461.653
2,771
Income Before Tax
-4,496
-
-4,022
-4,850
-3,846
-960.178
Income from Continuing Operations
-4,496
-
-4,022
-4,850
-3,846
-960.178
Net Income
-4,322
-
-3,890
-4,605
-3,717
-960.178
Net Income available to common shareholders
-4,322
-
-3,890
-4,605
-3,717
-960.178
Basic EPS
-0.04
-0.04
-0.03
-0.04
-0.03
-
Diluted EPS
-0.04
-0.04
-0.03
-0.04
-0.03
-
Basic Average Shares
112,600
127,120
120,702
112,600
108,614
-
Diluted Average Shares
112,600
127,120
120,702
112,600
108,614
-